SCHEMBL28934459

SCHEMBL28934459

Cc1ccc(-c2nnc(NC3CCCNC3)c3ccccc23)c(O)c1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 11/20 0.54
NLRP3 Q96P20 3/20 0.52
IL1B P01584 1/20 0.45
CHEK1 O14757 4/20 0.44
KDM4E B2RXH2 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CCNT1 O60563 2/20 0.42
CCNK O75909 2/20 0.42
CDK7 P50613 2/20 0.42
CDK9 P50750 2/20 0.42
CCNH P51946 2/20 0.42
MNAT1 P51948 2/20 0.42
CDK12 Q9NYV4 2/20 0.42
PRKCZ Q05513 1/20 0.42
PRKD2 Q9BZL6 1/20 0.42
CCNE1 P24864 1/20 0.42
CDK2 P24941 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28934455 1.00 CHEK2 (0.54) CHEK2NLRP3IL1BCHEK1KDM4E
SCHEMBL30108921 1.00 CHEK2 (0.54) CHEK2NLRP3IL1BCHEK1KDM4E
SCHEMBL30101107 0.93 NLRP3 (0.53) CHEK2NLRP3IL1BCHEK1CCNT1
SCHEMBL28934758 0.93 NLRP3 (0.53) CHEK2NLRP3IL1BCHEK1CCNT1
SCHEMBL28934748 0.93 NLRP3 (0.53) CHEK2NLRP3IL1BCHEK1CCNT1
SCHEMBL30108692 0.93 NLRP3 (0.53) CHEK2NLRP3IL1BCHEK1CCNT1
SCHEMBL28934751 0.93 NLRP3 (0.53) CHEK2NLRP3IL1BCHEK1CCNT1
SCHEMBL28934753 0.93 NLRP3 (0.53) CHEK2NLRP3IL1BCHEK1CCNT1
SCHEMBL28963452 0.88 NLRP3 (0.49) CHEK2NLRP3IL1BCHEK1CCNT1
SCHEMBL28934616 0.88 CHEK2 (0.48) CHEK2NLRP3IL1BCHEK1CCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116969920-A Fused pyridazine derivative, preparation method and medical application thereof 上海辉启生物医药科技有限公司 2023-10-31 CN disclosed
CN-115433163-A NLRP3 inflammasome inhibitor and application thereof 药捷安康(南京)科技股份有限公司 2022-12-06 CN disclosed